SEC
|
Kelly Thomas Patrick
|
Chief Financial Officer
|
|
-3K
|
$15.62
|
-$47.02K
|
|
SEC
|
Martin Daniel C.
|
Chief Commercial Officer
|
|
-2.3K
|
$15.62
|
-$35.41K
|
|
SEC
|
Pitman Jama
|
SVP, Chief Development Officer
|
|
-2.3K
|
$15.62
|
-$35.41K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
-2.6K
|
$15.62
|
-$40.85K
|
|
SEC
|
Kelly Thomas Patrick
|
Chief Financial Officer
|
|
-2.4K
|
$14.47
|
-$35.23K
|
|
SEC
|
Martin Daniel C.
|
Chief Commercial Officer
|
|
-1.6K
|
$14.47
|
-$23.50K
|
|
SEC
|
Pitman Jama
|
SVP, Chief Development Officer
|
|
-1.6K
|
$14.47
|
-$23.50K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
-2.4K
|
$14.47
|
-$35.23K
|
|
SEC
|
Hoerter Steven L.
|
President and CEO
|
|
-31K
|
$15.37
|
-$471.31K
|
|
SEC
|
Kelly Thomas Patrick
|
Chief Financial Officer
|
|
-2.8K
|
$15.37
|
-$42.91K
|
|
SEC
|
Martin Daniel C.
|
Chief Commercial Officer
|
|
-1.7K
|
$15.37
|
-$26.54K
|
|
SEC
|
Pitman Jama
|
See Remarks
|
|
-1.7K
|
$15.37
|
-$25.54K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
-2.8K
|
$15.37
|
-$42.91K
|
|
SEC
|
Martin Daniel C.
|
Chief Commercial Officer
|
|
-18K
|
$12.57
|
-$223.76K
|
|
SEC
|
Hoerter Steven L.
|
President and CEO
|
|
-22K
|
$12.02
|
-$259.31K
|
|
SEC
|
Kelly Thomas Patrick
|
Chief Financial Officer
|
|
-2.3K
|
$12.02
|
-$27.84K
|
|
SEC
|
Martin Daniel C.
|
Chief Commercial Officer
|
|
-1.4K
|
$12.02
|
-$16.91K
|
|
SEC
|
Pitman Jama
|
See Remarks
|
|
-1.4K
|
$12.02
|
-$16.91K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
-2.4K
|
$12.02
|
-$28.37K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
-2.9K
|
$12.68
|
-$37.30K
|
|
SEC
|
Flynn Daniel Lee
|
Chief Scientific Officer
|
|
-1.7K
|
$14.40
|
-$23.83K
|
|
SEC
|
Kelly Thomas Patrick
|
Chief Financial Officer
|
|
-1.7K
|
$14.40
|
-$23.83K
|
|
SEC
|
Martin Daniel C.
|
Chief Commercial Officer
|
|
-1.2K
|
$14.40
|
-$17.83K
|
|
SEC
|
Pitman Jama
|
See Remarks
|
|
-1.2K
|
$14.40
|
-$17.83K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
-1.7K
|
$14.40
|
-$23.83K
|
|
SEC
|
Friedman Franklin Stuart
|
N/A
|
|
+10K
|
$13.88
|
+$138.80K
|
|
SEC
|
Walsh Dennis Leo
|
N/A
|
|
+11K
|
$13.86
|
+$152.46K
|
|
SEC
|
Hoerter Steven L.
|
President and CEO
|
|
-7.5K
|
$15.57
|
-$116.78K
|
|
SEC
|
Flynn Daniel Lee
|
Chief Scientific Officer
|
|
+15K
|
$1.16
|
+$17.54K
|
|
SEC
|
Kelly Thomas Patrick
|
Chief Financial Officer
|
|
+15K
|
$1.16
|
+$17.54K
|
|
SEC
|
Martin Daniel C.
|
Chief Commercial Officer
|
|
+10K
|
$1.42
|
+$14.19K
|
|
SEC
|
Pitman Jama
|
See Remarks
|
|
+10K
|
$1.42
|
+$14.19K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
+16K
|
$0.84
|
+$13.03K
|
|
SEC
|
Hoerter Steven L.
|
President and CEO
|
|
-30K
|
$16.00
|
-$480.72K
|
|
SEC
|
Brightstar Associates LLC
|
N/A
|
|
+1.7M
|
$18.00
|
+$30.00M
|
|
SEC
|
Flynn Daniel Lee
|
Chief Scientific Officer
|
|
-2.4K
|
$21.24
|
-$51.04K
|
|
SEC
|
Kelly Thomas Patrick
|
Chief Financial Officer
|
|
-2.4K
|
$21.24
|
-$51.04K
|
|
SEC
|
Martin Daniel C.
|
Chief Commercial Officer
|
|
-1.6K
|
$21.24
|
-$34.05K
|
|
SEC
|
Pitman Jama
|
See Remarks
|
|
-1.6K
|
$21.24
|
-$34.05K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
-2.4K
|
$21.24
|
-$51.04K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
-2.6K
|
$18.73
|
-$48.45K
|
|
SEC
|
Flynn Daniel Lee
|
Chief Scientific Officer
|
|
-1.8K
|
$10.75
|
-$19.01K
|
|
SEC
|
Kelly Thomas Patrick
|
Chief Financial Officer
|
|
-1.8K
|
$10.75
|
-$19.01K
|
|
SEC
|
Martin Daniel C.
|
Chief Commercial Officer
|
|
-1.3K
|
$10.75
|
-$14.09K
|
|
SEC
|
Pitman Jama
|
See Remarks
|
|
-1.3K
|
$10.75
|
-$13.95K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
-1.8K
|
$10.75
|
-$19.01K
|
|
SEC
|
Brightstar Associates LLC
|
N/A
|
|
+1.5M
|
$10.00
|
+$14.79M
|
|
SEC
|
Hoerter Steven L.
|
President and CEO
|
|
-3.2K
|
$9.11
|
-$28.70K
|
|
SEC
|
Flynn Daniel Lee
|
Chief Scientific Officer
|
|
-1.4K
|
$9.05
|
-$12.36K
|
|
SEC
|
Kelly Thomas Patrick
|
Chief Financial Officer
|
|
-1.4K
|
$9.05
|
-$12.38K
|
|
SEC
|
Martin Daniel C.
|
Chief Commercial Officer
|
|
-1.1K
|
$9.05
|
-$10.37K
|
|
SEC
|
Pitman Jama
|
See Remarks
|
|
-1.1K
|
$9.05
|
-$10.37K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
-984
|
$9.05
|
-$8.91K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
-2.7K
|
$33.17
|
-$88.20K
|
|
SEC
|
Hoerter Steven L.
|
President and CEO
|
|
-3.2K
|
$43.02
|
-$135.51K
|
|
SEC
|
Flynn Daniel Lee
|
Chief Scientific Officer
|
|
+11K
|
$2.14
|
+$22.67K
|
|
SEC
|
Kelly Thomas Patrick
|
Chief Financial Officer
|
|
+11K
|
$2.20
|
+$23.27K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
+11K
|
$0.57
|
+$6.25K
|
|
SEC
|
Hoerter Steven L.
|
President and CEO
|
|
+1.1K
|
$25.40
|
+$27.38K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
+207
|
$34.43
|
+$7.13K
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
+2.7K
|
$34.43
|
+$92.86K
|
|
SEC
|
Taylor Michael Douglas
|
N/A
|
|
-15K
|
$64.80
|
-$972.00K
|
|
SEC
|
Bristol James Arthur
|
N/A
|
|
-24K
|
$53.57
|
-$1.26M
|
|
SEC
|
Sherman Matthew L
|
EVP & Chief Medical Officer
|
|
-2.6K
|
$51.15
|
-$134.63K
|
|
SEC
|
Hoerter Steven L.
|
President and CEO
|
|
+187
|
$25.40
|
+$4.75K
|
|
SEC
|
Flynn Daniel Lee
|
Chief Scientific Officer
|
|
+9K
|
$1.89
|
+$17.06K
|
|
SEC
|
Flynn Daniel Lee
|
Chief Scientific Officer
|
|
+130K
|
$1.89
|
+$245.70K
|
|
SEC
|
Hoerter Steven L.
|
President and CEO
|
|
+188
|
$25.40
|
+$4.78K
|
|
SEC
|
Hoerter Steven L.
|
President and CEO
|
|
+187
|
$25.40
|
+$4.75K
|
|
SEC
|
Hoerter Steven L.
|
President and CEO
|
|
+188
|
$25.40
|
+$4.78K
|
|
SEC
|
Hoerter Steven L.
|
President and CEO
|
|
+187
|
$25.40
|
+$4.75K
|
|
SEC
|
Hoerter Steven L.
|
President and CEO
|
|
-10K
|
$35.64
|
-$362.46K
|
|
SEC
|
Flynn Daniel Lee
|
Chief Scientific Officer
|
|
+67K
|
$5.80
|
+$388.05K
|
|
SEC
|
Flynn Daniel Lee
|
Chief Scientific Officer
|
|
-31K
|
$60.00
|
-$1.86M
|
|
SEC
|
Martin Daniel C.
|
Chief Commercial Officer
|
|
-3K
|
$35.56
|
-$106.68K
|
|
SEC
|
New Leaf BPO Associates I, L.P.
|
N/A
|
|
-350K
|
$36.42
|
-$12.75M
|
|
SEC
|
Flynn Daniel Lee
|
Chief Scientific Officer
|
|
-25K
|
$23.20
|
-$580.00K
|
|
SEC
|
Flynn Daniel Lee
|
Chief Scientific Officer
|
|
+25K
|
$3.95
|
+$96.78K
|
|
SEC
|
Flynn Daniel Lee
|
Chief Scientific Officer
|
|
-153K
|
$26.00
|
-$3.97M
|
|
SEC
|
Flynn Daniel Lee
|
Chief Scientific Officer
|
|
-300
|
$26.00
|
-$7.80K
|
|
SEC
|
New Leaf BPO Associates I, L.P.
|
N/A
|
|
+4.1M
|
$17.00
|
+$69.77M
|
|
SEC
|
Ratcliffe Liam
|
N/A
|
|
+4.1M
|
$17.00
|
+$69.77M
|
|